234 related articles for article (PubMed ID: 15057003)
1. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers.
Méry L; Girot R; Aractingi S
Dermatology; 2004; 208(2):135-7. PubMed ID: 15057003
[TBL] [Abstract][Full Text] [Related]
2. Molgramostim to treat SS-sickle cell leg ulcers.
Pieters RC; Rojer RA; Saleh AW; Saleh AE; Duits AJ
Lancet; 1995 Feb; 345(8948):528. PubMed ID: 7861910
[No Abstract] [Full Text] [Related]
3. Topical GM-CSF hastens healing of leg ulcers in sickle cell disease.
Alikhan MA; Carter G; Mehta P
Am J Hematol; 2004 Jun; 76(2):192. PubMed ID: 15164391
[No Abstract] [Full Text] [Related]
4. Topical effectiveness of filgrastim in beta-thalassaemia leg ulcer.
Stavrianeas N; Xifteri A; Kavatha D; Vrettou H
Dermatology; 2005; 211(2):173;author reply 173. PubMed ID: 16088173
[No Abstract] [Full Text] [Related]
5. Treatment of chronic leg ulcers with topical activated protein C.
Whitmont K; Reid I; Tritton S; March L; Xue M; Lee M; Fulcher G; Sambrook P; Slobedman E; Cooper A; Jackson C
Arch Dermatol; 2008 Nov; 144(11):1479-83. PubMed ID: 19015423
[TBL] [Abstract][Full Text] [Related]
6. Rapid healing of chronic leg ulcers during perilesional injections of granulocyte-macrophage colony-stimulating factor therapy in a patient with cutaneous polyarteritis nodosa.
Tursen U; Api H; Kaya TI; Cinel L; Ikizoglu G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1341-3. PubMed ID: 17062064
[No Abstract] [Full Text] [Related]
7. Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment.
Remes K; Rönnemaa T
J Diabetes Complications; 1999; 13(2):115-8. PubMed ID: 10432176
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human GM-CSF in the treatment of poorly healing wounds.
Groves RW; Schmidt-Lucke JA
Adv Skin Wound Care; 2000; 13(3 Pt 1):107-12. PubMed ID: 11075003
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell leg ulcers: a frequently disabling complication and a marker of severity.
Halabi-Tawil M; Lionnet F; Girot R; Bachmeyer C; Lévy PP; Aractingi S
Br J Dermatol; 2008 Feb; 158(2):339-44. PubMed ID: 18047512
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose topical recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) therapy for chronic venous leg ulcers, 10-year follow-up].
Jaschke E; Umlauft J; Palmer-Reichel K; Oberaigner W; Schmuth M
Dermatologie (Heidelb); 2023 Jan; 74(1):41-48. PubMed ID: 36287238
[TBL] [Abstract][Full Text] [Related]
11. Recombinant granulocyte macrophage colony stimulating factor (rhu-GM-CSF) in the treatment of extensive leg ulcers: a case report.
Siddiqui FH; Biundo JJ; Moore C; Ermitaño ML; Ortigas AP; DeFrancesch F
Surgery; 2000 May; 127(5):589-92. PubMed ID: 10819070
[No Abstract] [Full Text] [Related]
12. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers.
Jaschke E; Zabernigg A; Gattringer C
Int J Dermatol; 1999 May; 38(5):380-6. PubMed ID: 10369552
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte-macrophage colony-stimulating factor as treatment for chronic leg ulcers.
Borbolla-Escoboza JR; María-Aceves R; López-Hernández MA; Collados-Larumbe MT
Rev Invest Clin; 1997; 49(6):449-51. PubMed ID: 9528304
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell leg ulcers in Ghana.
Ankra-Badu GA
East Afr Med J; 1992 Jul; 69(7):366-9. PubMed ID: 1396190
[TBL] [Abstract][Full Text] [Related]
15. Recombinant granulocyte-macrophage colony-stimulating factor in the treatment of indolent ulcers with Klippel-Trénaunay-Weber syndrome: a case report.
Siddiqui FH; Mokhashi MH; Boathman A
J Pediatr Surg; 2007 Mar; 42(3):558-60. PubMed ID: 17336199
[TBL] [Abstract][Full Text] [Related]
16. Quick healing of leg ulcers after molgramostim.
da Costa RM; Aniceto C; Jesus FM; Mendes M
Lancet; 1994 Aug; 344(8920):481-2. PubMed ID: 7914596
[No Abstract] [Full Text] [Related]
17. Factor XIII in ulcerative leg disease: background and preliminary clinical results.
Wozniak G; Dapper F; Alemany J
Semin Thromb Hemost; 1996; 22(5):445-50. PubMed ID: 8989829
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.
Jyung RW; Wu L; Pierce GF; Mustoe TA
Surgery; 1994 Mar; 115(3):325-34. PubMed ID: 7510423
[TBL] [Abstract][Full Text] [Related]
19. Wound healing of chronic leg ulcers under the influence of erysipelas.
Trebing D; Göring HD
Eur J Dermatol; 2004; 14(1):56-7. PubMed ID: 14965798
[TBL] [Abstract][Full Text] [Related]
20. New clinical applications of granulocyte-macrophage colony-stimulating factor.
Masucci G
Med Oncol; 1996 Sep; 13(3):149-54. PubMed ID: 9106173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
